1. Home
  2. MYRG vs IDYA Comparison

MYRG vs IDYA Comparison

Compare MYRG & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MYR Group Inc.

MYRG

MYR Group Inc.

N/A

Current Price

$211.30

Market Cap

3.5B

Sector

Industrials

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$33.58

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYRG
IDYA
Founded
1891
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MYRG
IDYA
Price
$211.30
$33.58
Analyst Decision
Buy
Strong Buy
Analyst Count
8
14
Target Price
$214.14
$49.42
AVG Volume (30 Days)
273.0K
908.2K
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
169.25
N/A
EPS
6.17
N/A
Revenue
$3,514,140,000.00
$214,834,000.00
Revenue This Year
$8.62
$2,434.86
Revenue Next Year
$9.67
N/A
P/E Ratio
$35.36
N/A
Revenue Growth
N/A
5377.66
52 Week Low
$97.72
$13.45
52 Week High
$241.13
$37.08

Technical Indicators

Market Signals
Indicator
MYRG
IDYA
Relative Strength Index (RSI) 41.96 50.36
Support Level $209.38 $33.10
Resistance Level $230.12 $34.45
Average True Range (ATR) 9.74 1.39
MACD -1.45 -0.35
Stochastic Oscillator 5.17 9.55

Price Performance

Historical Comparison
MYRG
IDYA

About MYRG MYR Group Inc.

MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: